drugset / Trial / NCT07674446

Dimotec (Diosmin) 1000 mg Film Coated Tablet Fed Study

NCT07674446

Phase 1 Recruiting 72 enrolled Keri Pharma Hungary Kft
RandomizedCrossoverOpen-labelTreatment

Summary

This study aims to compare the bioavailability of Dimotec 1000 mg film-coated tablet (Test; Keri Pharma Hungary Kft.) with Detralex 1000 mg film-coated tablets (Reference; Les Laboratoires Servier Industrie, France) in healthy adult human participants under fed conditions. The study will also evaluate the safety and tolerability of a single dose of the investigational products.

Timeline

Start
2026-06-29
Primary completion
2026-08-16
Completion
2026-12-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Diosmin Small molecule 1000 mg Oral

Indications

No indication recorded.